557 POSTER Pre-clinical activity of the PARP inhibitor AZD2281 in homologous recombination repair deficient triple negative breast cancer
M.J. O'Connor, A. Lau, R.S. Finn, C. Knights, A. O'Shaughnessy, O. Kalous, D. Conklin, L. Riches, J. Carmichael, D.J. SlamonVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72491-1
File:
PDF, 72 KB
english, 2008